Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Radiology and Oncology
Volume 41 (2007): Issue 1 (March 2007)
Open Access
Testing of mechanisms of action of rituximab and clinical results in high-risk patients with aggressive CD20+ lymphoma
Barbara Novaković
Barbara Novaković
,
Vladimir Kotnik
Vladimir Kotnik
,
Tanja Šetina
Tanja Šetina
,
Marjeta Vovk
Marjeta Vovk
and
Srdjan Novaković
Srdjan Novaković
| Apr 30, 2007
Radiology and Oncology
Volume 41 (2007): Issue 1 (March 2007)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Apr 30, 2007
Page range:
23 - 32
DOI:
https://doi.org/10.2478/v10019-007-0004-y
Keywords
lymphoma
,
B-cell - therapy
,
antigens
,
CD 20
,
antibodies
,
monoclonal
This content is open access.
Barbara Novaković
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Vladimir Kotnik
Institute of Microbiology and Immunology, Medical Faculty Ljubljana, Ljubljana, Slovenia
Tanja Šetina
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Marjeta Vovk
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Srdjan Novaković
Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia